- GLP
- GMP
About
Axolabs provides CRO and CDMO services for nucleic acid therapeutics, including oligonucleotides and RNA modalities. It works from sites in Petaluma, USA, and Berlin and supports projects from discovery and preclinical work through GMP manufacturing and clinical supply.
Services
In silico & bioinformatics
Uses proprietary algorithms and sequence modeling to predict off-target interactions and support rational lead selection before benchwork begins.
Assays & in vitro testing
Rational design & synthesis
Performs chemical modification and solid-phase synthesis to improve oligonucleotide stability, reduce immunogenicity, and enable targeted delivery.
Assays & in vitro testing
Preclinical screening
Evaluates oligonucleotide libraries with automated synthesis, rapid purification, and multiplexed assays for efficacy, specificity, and safety.
Assays & in vitro testing
Cell-based evaluations
Uses in vitro platforms to assess on-target effects, cytotoxicity, and immunostimulation for early go/no-go decisions.
Assays & in vitro testing
Advanced bioanalytics
Applies proprietary PNA-HPLC, LC-MS/MS, and cytokine profiling to study kinetics, biodistribution, metabolism, and immune responses.
Assays & in vitro testing
mRNA analytics
Provides analytical characterization and bioanalytical support for mRNA therapeutics and vaccines, including critical quality attributes and pharmacology studies.
Assays & in vitro testing
LNP Formulation Services
Offers LNP formulation and characterization support for RNA therapeutics.
Assays & in vitro testing
Early-stage oligonucleotide synthesis & lead optimisation
Provides high-throughput early-stage synthesis for multiple RNA modalities using 96-well platforms and conjugation chemistry for ligand modifications.
Large-scale oligonucleotide manufacturing
Delivers pilot to commercial scale manufacturing of oligonucleotides using Cytiva and AKB THESYS platforms.
CDMO: development & manufacturing
cGMP production
Provides dual-site cGMP manufacturing for oligonucleotide therapeutics for clinical and initial commercial supply.
CDMO: development & manufacturing
GMP analytics & quality control
Supports manufacturing with analytical QC and release testing using chromatographic and LC-MS methods.
Assays & in vitro testing
Integrated technology transfer
Coordinates transfer from discovery and pilot scale into scalable CDMO and GMP manufacturing workflows.
- What to send
- Synthesis request form (.xlsx) to be completed and sent to orders@axolabs.com
Capabilities
- Assays and studies
- Oligonucleotides · Bioanalysis · mRNA · Analytical development · LNP · LC-MS/MS · HPLC · Immunogenicity · RNA-Seq-based off-target analysis · PNA assay · Cell-based functional testing · Quantigene™
10 more
qPCR · RNA-Seq · xCELLigence® · Flow cytometry · PNA-HPLC · Cytokine profiling · uHPLC · AEX · RP · SEC - Scale and capacity
- 96-well platforms · Up to 300 mmol batch capacity · Milligram to kilogram batches · Dual-site cGMP manufacturing
Instruments and platforms
- Cytiva OligoPilot™
- Cytiva OligoProcess™
- Asahi Kasei Bioprocess (AKB THESYS™)
- AKB THESYS™ Synth100
- AKB THESYS™ Synth1500
- xCELLigence®
Modalities and species
- Modalities
- ADC · Oligonucleotide · mRNA · Vaccine · LNP / formulation
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: bioanalysis
GMPSelf-reported
Scope: manufacturing and compliance
Company
- Type
- CRDMO
- Founded
- 2000
Locations
- Based in
- Kulmbach, Germany
- Sites
- Petaluma, USA · Berlin, Germany · Kulmbach, Germany
- Serves
- global
- BfR GLP site
- Axolabs GmbH, Kulmbach, DE source
Contacts
Public records
- GLP
- In compliance · BfR source
Similar labs
Work here? Claim this listing